Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Gadolinium Ethoxybenzyl Dtpa
Therapeutic Area : Oncology
Study Phase : Phase IV
Sponsor : Bracco | National Cancer Institute
Deal Size : Inapplicable
Deal Type : Inapplicable
Comparison of Contrast Agents in Liver MR for the Detection of Hepatic Metastases
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
July 22, 2021
Lead Product(s) : Gadolinium Ethoxybenzyl Dtpa
Therapeutic Area : Oncology
Highest Development Status : Phase IV
Sponsor : Bracco | National Cancer Institute
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Gadolinium Ethoxybenzyl Dtpa
Therapeutic Area : Neurology
Study Phase : Phase IV
Sponsor : Bayer AG | Bracco | GE Healthcare
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
May 04, 2020
Lead Product(s) : Gadolinium Ethoxybenzyl Dtpa
Therapeutic Area : Neurology
Highest Development Status : Phase IV
Sponsor : Bayer AG | Bracco | GE Healthcare
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Gadolinium Ethoxybenzyl Dtpa
Therapeutic Area : Oncology
Study Phase : Phase IV
Sponsor : Nova Scotia Health Authority
Deal Size : Inapplicable
Deal Type : Inapplicable
Improving CBCT for Liver IG-SBRT Using Gadoxetate Disodium
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
July 12, 2017
Lead Product(s) : Gadolinium Ethoxybenzyl Dtpa
Therapeutic Area : Oncology
Highest Development Status : Phase IV
Sponsor : Nova Scotia Health Authority
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Gadolinium Ethoxybenzyl Dtpa
Therapeutic Area : Undisclosed
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
March 12, 2014
Lead Product(s) : Gadolinium Ethoxybenzyl Dtpa
Therapeutic Area : Undisclosed
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable